Guangnong Zhang

Company: Dicerna TRU of Novo Nordisk

Job title: Associate Director

Seminars:

Panel Discussion: RNAi 2.0; Evaluating RNAi Therapeutics of the Future 10:00 am

This panel discussion will take a look into the future about the hope and promise of RNAi therapeutics. The panel will discuss: Why gene silencing over other RNA therapeutics? What needs to be done for RNAi to become the first line of therapy? What are the pros and cons of gene silencing compared with other…Read more

day: Day One